Johnson &amp; Johnson says Covid-19 vaccine could be ready next year  DUBAI , 13 hours , 36 minutes ago  Global healthcare major Johnson &amp; Johnson said it aims to begin the clinical testing of its Covid-19 vaccine in humans by September and added that the first batches of the vaccine could be available for emergency use authorisation ( EUA ) early next year .
Johnson &amp; Johnson said a landmark new partnership has been inked between its unit , Janssen Pharmaceutical Companies .
and the Biomedical Advanced Research and Development Authority ( Barda ) on the rapid scaling of the company 's manufacturing capacity with the goal of providing global supply of more than one billion doses of a vaccine .
The company expects to initiate human clinical studies of its lead vaccine candidate at the latest by September and anticipates the first batches of a Covid-19 vaccine could be available for emergency use authorization in early 2021 , a substantially accelerated timeframe in comparison to the typical vaccine development process .
Johnson &amp; Johnson began efforts in January 2020 , as soon as the novel coronavirus ( Covid-19 ) sequence became available @ @ @ @ @ @ @ @ @ @ the deal , Barda , which is part of the Office of the Assistant Secretary for Preparedness and Response ( ASPR ) at the US Department of Health and Human Services , and Johnson &amp; Johnson will together invest more than $1 billion for vaccine research , development , and clinical testing .
The company said it will use its validated vaccine platform and is allocating resources , including personnel and infrastructure globally , as needed , to focus on these efforts .
Separately , Barda and Johnson &amp; Johnson have provided additional funding that will enable expansion of their ongoing work to identify potential antiviral treatments against the novel coronavirus .
As part of its commitment , the top pharma giant is also expanding its global manufacturing capacity , including through the establishment of new US vaccine manufacturing capabilities and scaling up capacity in other countries .
The additional capacity will assist in the rapid production of a vaccine and will enable the supply of more than one billion doses of a safe and effective vaccine globally .
Johnson &amp; Johnson plans to begin @ @ @ @ @ @ @ @ @ @ affordable vaccine to the public on a not-for-profit basis for emergency pandemic use , said its top official .
" The world is facing an urgent public health crisis and we are committed to doing our part to make a Covid-19 vaccine available and affordable globally as quickly as possible , " remarked its Chairman and CEO Alex Gorsky .
" As the world 's largest healthcare company , we feel a deep responsibility to improve the health of people around the world every day .
Johnson &amp; Johnson is well positioned through our combination of scientific expertise , operational scale and financial strength to bring our resources in collaboration with others to accelerate the fight against this pandemic , " he added .
-TradeArabia News Service .
